title: The therapy of acute leukemia in the adult: a progress report.
mesh_terms: D000208:Acute Disease; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use; D001803:Blood Transfusion; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D010356:Patient Isolation; D017713:Platelet Transfusion; D011014:Pneumonia / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013866:Thioguanine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D009353:Zinostatin / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; D014750:Vincristine; D005047:Etoposide; D003907:Dexamethasone; D009353:Zinostatin; D013866:Thioguanine; D001374:Azacitidine; D011241:Prednisone; D011739:Pyrimethamine; D003630:Daunorubicin